Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

The zoonotic potential of epidemic porcine deltacoronavirus

The present state of knowledge about the genesis, evolution, cross-species transmission, and zoonotic potential of PDCoV is the subject of a review published in the journal Pathogens, which was conducted in a combined effort by researchers from Heilongjiang Bayi Agricultural University and Ohio State University.

13 Jan 2022

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

Recently, the researchers from the USA, in their study published in the journal EBioMedicine, have conducted a sequence identity comparison and 3D protein structure comparison between the SARS-CoV-2 spike protein-derived peptides/protein and myocarditis-associated antigens and have found no significant enrichment in the frequency of spike-derived peptides similar to myocarditis-associated antigens that could have resulted in adaptive autoimmune responses leading to myocarditis.

12 Jan 2022

How did the COVID pandemic affect the spread of other zoonotic diseases?

In new research, scientists from the Beijing University of Technology have been investigating the impact of the COVID-19 pandemic on the incidence and mortality of zoonotic diseases in China. Their work is published in the journal BMJ Global Health.

12 Jan 2022

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

Researchers examine the effects of disease-modifying therapies implemented for treating multiple sclerosis on the immune response to SARS-CoV-2 infection.

12 Jan 2022

The impact of Comirnaty vaccination on the levels of PEG specific antibodies

Researchers observe an increase in PEG antibodies following vaccination with the SARS-CoV-2 mRNA lipid nanoparticle vaccine.

12 Jan 2022

How much protection does SARS-CoV-2 infection provide against reinfection?

Researchers determine whether previous SARS-CoV-2 infection protects from reinfection.

12 Jan 2022

High SARS-CoV-2 seroprevalence among captive white-tailed deer in Texas

Researchers investigate the SARS-CoV-2 exposure and infection status of captive white-tailed deer in Texas.

12 Jan 2022

Estimating transmission advantage of SARS-CoV-2 Omicron over Delta in the UK

Researchers estimate daily growth rates for the SARS-CoV-2 Omicron and Delta variants in each UKHSA region of England.

12 Jan 2022

Dynamics of hospital-acquired SARS-CoV-2 infection in a geriatric setting

Researchers investigated the extent of nosocomial SARS-CoV-2 infection among elderly patients and healthcare workers in a geriatric hospital.

12 Jan 2022

Greater psychological distress linked with higher SARS-CoV-2 infection risk

A new study has found that people who experienced increased stress, anxiety and depression at the start of the pandemic, were at greater risk of getting Covid-19.

12 Jan 2022

Study: Face masks reduce the distance airborne pathogens could travel by more than half

The effectiveness of face masks has been a hotly debated topic since the emergence of COVID-19. However, a new study by researchers at the University of Central Florida offers more evidence that they work.

12 Jan 2022

Ask KHN-Politifact: Is my cloth mask good enough? The 2022 edition

The highly transmissible omicron variant is sweeping the U.S., causing a huge spike in covid-19 cases and overwhelming many hospital systems.

12 Jan 2022

Comparing the Moderna and Pfizer-Biontech vaccines against SARS-CoV-2 infection

A new study used target trial emulation design for comparison of both the vaccines in the VA healthcare system against the risk of infection, hospitalization, and death from COVID-19.

12 Jan 2022

New method for monitoring circulating SARS-CoV-2 variants and detecting new ones

To understand and act early and appropriately to emerging variants of concern, researchers have explored the possibility of having a variant-agnostic detection assay.

12 Jan 2022

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

A new study, posted to the medRxiv* preprint server, has focussed on the development of intranasal prophylaxis against SARS-CoV-2 infection.

11 Jan 2022

Airborne decay of SARS-CoV-2 occurs within minutes

A new study, posted to the medRxiv* preprint server, has focused on the survival of SARS-CoV-2 in airborne droplets of cell culture medium.

11 Jan 2022

SARS-CoV-2 and pepper mild mottle virus RNA highly persistent in wastewater solids

A new study from the United States (US) investigates the persistence (lifetime) of viral ribonucleic acid (RNA) under different ambient conditions within wastewater infrastructure to understand how it impacts RNA measurements and the related wastewater epidemiology.

11 Jan 2022

A common cold may boost the immune system against COVID-19

A recent groundbreaking research paper published in the journal Nature Communications reveals the association of circulating SARS-CoV-2-specific T cells at exposure with lack of infection – implying the protective role for cross-reactive immune T cells in coronavirus disease 2019 (COVID-19) and opening the door for second-generation vaccines that could circumvent spike-antibody immune escape variants.

11 Jan 2022

Common framework evaluates the global health impact of drugs and aids in identifying shortcomings

A common framework that standardizes health impact across diseases and their interventions can aid in identifying current shortcomings on a global scale, according to new research from Binghamton University, State University of New York.

11 Jan 2022

AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery

The iMolecule group from Skoltech has developed an artificial intelligence-driven solution that uses data on the structure of RNA or DNA molecules to identify sites on them where interaction with potential drug candidates can occur.

11 Jan 2022